{"company": {"org_id": "Q015FBC317", "org_name_cn": "首药控股(北京)股份有限公司", "org_short_name_cn": "首药控股", "org_name_en": "Shouyao Holdings Co.,Ltd.", "org_short_name_en": "Shouyao Holdings", "main_operation_business": "肿瘤和糖尿病药物的研发。", "operating_scope": "　　一般项目：以自有资金从事投资活动；自有资金投资的资产管理服务；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；货物进出口；技术进出口；医学研究和试验发展。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：药品委托生产。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）（不得从事国家和本市产业政策禁止和限制类项目的经营活动。）", "district_encode": "110115", "org_cn_introduction": "首药控股(北京)股份有限公司的主营业务是肿瘤和糖尿病药物的研发。公司的主要产品是技术开发及服务。", "legal_representative": "李文军", "general_manager": "李文军", "secretary": "张英利", "established_date": 1460995200000, "reg_asset": 148719343.0, "staff_num": 178, "telephone": "86-10-88857906", "postcode": "100195", "fax": "86-10-88853760", "email": "shouyaoholding@163.com", "org_website": "www.shouyaoholding.com", "reg_address_cn": "北京市大兴区北京经济技术开发区荣华中路10号1幢A座22层2205", "reg_address_en": null, "office_address_cn": "北京市海淀区闵庄路3号玉泉慧谷科技园15号楼", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1647964800000, "provincial_name": "北京市", "actual_controller": "李文军 (52.11%)", "classi_name": "民营企业", "pre_name_cn": "首药控股(北京)有限公司", "chairman": "李文军", "executives_nums": 16, "actual_issue_vol": 37180000.0, "issue_price": 39.9, "actual_rc_net_amt": 1373754021.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.03555684, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}